148 related articles for article (PubMed ID: 3089808)
1. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
Reuben A; Qureshi Y; Murphy GM; Dowling RH
Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
[TBL] [Abstract][Full Text] [Related]
2. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
Reuben A; Maton PN; Murphy GM; Dowling RH
Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
[TBL] [Abstract][Full Text] [Related]
3. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
[TBL] [Abstract][Full Text] [Related]
4. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
6. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
7. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
Iser JH; Murphy GM; Dowling RH
Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
[TBL] [Abstract][Full Text] [Related]
9. Bilary lipid metabolism in obesity. Effects of bile acid feeding before and during weight reduction.
Mok HY; von Bergmann K; Crouse JR; Grundy SM
Gastroenterology; 1979 Mar; 76(3):556-67. PubMed ID: 428710
[TBL] [Abstract][Full Text] [Related]
10. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
Grundy SM; Lan SP; Lachin J
J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
[TBL] [Abstract][Full Text] [Related]
11. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
12. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
13. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
14. Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution.
Pérez-Aguilar F; Bretó M; Alegre B; Berenguer J
Digestion; 1985; 31(4):225-33. PubMed ID: 4007294
[TBL] [Abstract][Full Text] [Related]
15. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
[TBL] [Abstract][Full Text] [Related]
16. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
17. Comparison of biliary lipid secretion in non-obese cholesterol gallstone patients with normal, young, male volunteers.
Leiss O; von Bergmann K
Klin Wochenschr; 1985 Nov; 63(22):1163-9. PubMed ID: 4079281
[TBL] [Abstract][Full Text] [Related]
18. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
Iser JH; Dowling H; Mok HY; Bell GD
N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
[TBL] [Abstract][Full Text] [Related]
20. Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.
Bateson MC; Ross PE; Murison J; Bouchier IA
Gut; 1977 Aug; 18(8):599-605. PubMed ID: 330352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
